Literature DB >> 15886251

Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome.

Iqbal Munir1, Hui-Wen Yen, Talia Baruth, Rafal Tarkowski, Ricardo Azziz, Denis A Magoffin, Artur J Jakimiuk.   

Abstract

CONTEXT: A newly discovered hormone resistin has been shown to be increased in women with polycystic ovary syndrome (PCOS).
OBJECTIVE: The purpose of this study was to confirm increased resistin concentrations in women with PCOS and to test the direct effect of resistin on human theca cell androgen production.
DESIGN: Resistin was measured in fasting serum samples by RIA. To test the direct effects of resistin on ovarian androgen biosynthesis, human theca cells were cultured with resistin for 3 d in the presence and absence of forskolin and insulin. PATIENTS: Fasting serum samples were obtained from 45 women with PCOS and 74 regularly cycling premenopausal control women in the follicular phase of their menstrual cycles, and ovarian theca cell cultures were established from two control women.
RESULTS: The mean serum resistin concentration was increased (40%) in women with PCOS. Serum resistin concentrations correlated positively with body mass index and testosterone in PCOS women but not in controls. There were no significant correlations between resistin and fasting insulin or indicators of insulin resistance when corrected for body mass index. In cultured human theca cells, basal 17alpha-hydroxylase activity was unchanged by resistin alone, but resistin enhanced 17alpha-hydroxylase activity in the presence of forskolin or a combination of forskolin plus insulin. Resistin (> or =1 ng/ml) augmented forskolin and forskolin plus insulin stimulation of CYP17 mRNA expression in a concentration-dependent manner.
CONCLUSION: These data indicate that abnormal resistin secretion in PCOS may play a role in causing ovarian hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886251     DOI: 10.1210/jc.2004-2152

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.

Authors:  Charalampos Siristatidis; Marily Askoxylaki; Christos Varounis; Dimitrios Kassanos; Charalampos Chrelias
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

Review 2.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

3.  Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.

Authors:  Sanaz Mehrabani; Arman Arab; Elham Karimi; Mehran Nouri; Marjan Mansourian
Journal:  Reprod Sci       Date:  2021-09-01       Impact factor: 2.924

4.  Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.

Authors:  Fatemeh Farshchian; Fahimeh Ramezani Tehrani; Houshang Amirrasouli; Hooman Rahimi Pour; Mehdi Hedayati; Faranak Kazerouni; Adeleh Soltani
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

Review 5.  Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Anna Lalik; Graça Soveral
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

6.  Effects of resistin on porcine ovarian follicle steroidogenesis in prepubertal animals: an in vitro study.

Authors:  Agnieszka Rak-Mardyła; Martyna Durak; Ewa Lucja Gregoraszczuk
Journal:  Reprod Biol Endocrinol       Date:  2013-05-17       Impact factor: 5.211

7.  Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).

Authors:  Pascal Froment; Philippe Touraine
Journal:  PPAR Res       Date:  2006       Impact factor: 4.964

Review 8.  Cardiometabolic aspects of polycystic ovarian syndrome.

Authors:  Li Wei Cho; Harpal S Randeva; Stephen L Atkin
Journal:  Vasc Health Risk Manag       Date:  2007

Review 9.  Adipokines and the female reproductive tract.

Authors:  Maxime Reverchon; Christelle Ramé; Michael Bertoldo; Joëlle Dupont
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

10.  Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?

Authors:  Alice Bongrani; Namya Mellouk; Christelle Rame; Marion Cornuau; Fabrice Guérif; Pascal Froment; Joëlle Dupont
Journal:  Int J Mol Sci       Date:  2019-08-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.